Related Experiment Video
Updated: Jan 16, 2026

Imaging Approaches to Assessments of Toxicological Oxidative Stress Using Genetically-encoded Fluorogenic Sensors
Published on: February 7, 2018
Exploration of oxidative stress-mediated genetic toxicology modes of action using a pathway analysis, Connectivity
K Nadira De Abrew1, Bastian G Selman2, Mahmoud Shobair2
1Ivorydale Innovation Center, The Procter & Gamble Company, Cincinnati, OH 45217, United States.
Abstract:
Although current genetic toxicology practices can detect downstream genotoxicity effects, such as gene mutation and double-strand breaks, they are unable to detect the underlying mode of action (MoA) of a chemical or differentiate between direct- and indirect-acting genotoxicants without additional modification. The Adverse Outcome Pathway (AOP) framework is a useful tool to critically identify and evaluate MoAs and can enable subsequent quantitative dose-response assessments of genotoxicity endpoints. The recently developed AOP, "Oxidative DNA damage leading to chromosomal aberrations and mutations" (https://aopwiki.org/aops/296), pertains to 1 common genetic toxicology-relevant MoA: Oxidative stress. Reactive oxygen species (ROS) play a key role in regulating many biological processes; however, when disrupted, an excess of ROS can eventually lead to DNA damage and double-strand breaks. Here, we look at 18 compounds reported to have complete or mixed oxidative stress MoAs and use a combination of genomic tools such as Pathway analysis, Connectivity Mapping (CMap), and Transcriptional benchmark dose modeling to define a framework that can separate substances that test negative in vivo from true in vivo genotoxicants. TK6 cells were treated with the 18 compounds for 4 h, parallel micronucleus and genomics experiments were performed, and in vitro micronucleus data were used to infer dose for genomics analysis. The resulting genomic data were analyzed using pathway analysis for hypothesis generation; these hypotheses were tested using CMap and Transcriptional benchmark dose modeling. We demonstrate that a genomics-based workflow based on in vitro methods can be used to successfully separate in vivo genotoxicants from non-genotoxicants. These methods have the potential to evolve into Next Generation Risk Assessment tools that can be used for determining the contribution of the oxidative stress MoA in a predictive toxicology setting.
Insights
This study introduces a new genomic framework to identify genotoxic chemicals by analyzing oxidative stress mechanisms. The approach successfully distinguishes true genotoxicants from non-genotoxicants using in vitro data, advancing predictive toxicology.
Area of Science:
- Toxicology and Genomics
- Adverse Outcome Pathways (AOPs)
- Predictive Toxicology
Background:
- Current genetic toxicology methods lack the ability to identify the specific mode of action (MoA) of chemicals or differentiate between direct and indirect genotoxicants.
- The Adverse Outcome Pathway (AOP) framework offers a structured approach to evaluate MoAs and dose-response relationships in genotoxicity.
- Oxidative stress, involving reactive oxygen species (ROS), is a significant MoA linked to DNA damage and mutations.
Purpose of the Study:
- To develop and validate a genomic framework for differentiating in vivo genotoxicants from non-genotoxicants.
- To utilize the AOP for Oxidative DNA damage to investigate compounds with oxidative stress MoAs.
- To establish a workflow for Next Generation Risk Assessment (NGRA) tools in predictive toxicology.
Main Methods:
- Treatment of TK6 cells with 18 compounds exhibiting oxidative stress MoAs.
- Application of genomic tools including Pathway analysis, Connectivity Mapping (CMap), and Transcriptional benchmark dose modeling.
- Integration of in vitro micronucleus data to infer dose for genomic analyses.
Main Results:
- A genomics-based workflow effectively separated in vivo genotoxicants from non-genotoxicants.
- Pathway analysis generated hypotheses, which were subsequently tested using CMap and Transcriptional benchmark dose modeling.
- The study demonstrates the utility of in vitro genomic data for predicting in vivo genotoxicity.
Conclusions:
- A genomics-driven workflow, utilizing in vitro data, can successfully classify substances based on their in vivo genotoxic potential.
- This approach has the potential to enhance the accuracy and efficiency of genotoxicity testing.
- The developed framework supports the advancement of predictive toxicology and NGRA tools for assessing oxidative stress-related MoAs.

